secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001104659-23-020879
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sesen Bio raises special dividend to $75M, extends CVR through 2027; activist investors back merger
--------------------------------------------------------------------------------

- Special cash dividend increased to $75M ($0.36/share) from prior ~$70M; up from original $25M.
- CVR period for Vicineum proceeds extended from Dec 31, 2023 to March 31, 2027.
- Bradley Radoff and Michael Torok (8.7% stake) vote for merger; Torok to join Carisma board.
- Special meeting to approve merger set for March 2, 2023; closing expected Q1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465923020879/0001104659-23-020879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465923020879/tm236507d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-020879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer